Ads
related to: bristol-myers squibb stock price today- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- Chipmaker Set to Soar Now
tradewins.com has been visited by 10K+ users in the past month
Search results
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
10 Health Care Stocks With Whale Alerts In Today's Session - Annovis Bio (NYSE:ANVS), Bristol-Myers ...
Benzinga· 2 days agoIt expires in 38 day(s) on June 21, 2024 . Parties traded 1790 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $930.8K , with a price< ...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 2 days agoHe has a buy rating and 108 price target on Cytokinetics stock. Blum estimates just 5% of patients...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 3 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 4 days agoAt its recent market price of $44.74 per share, that means the company is available for around 6.5...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks via Yahoo Finance· 7 days agoNet loss for 2024 is expected in the band of $229-$255 million. PRTA currently carries a Zacks Rank...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 7 days agoHighly Rated Biotech Stock Today, Neurocrine stock has a strong Composite Rating of 97 out of a...
Bull of the Day: Veeva Systems (VEEV)
Zacks via Yahoo Finance· 3 days agoThe tech firm and the stock are proven winners. Now might be the time for investors to heed tried-and-true investment advice and buy Veeva while others...
European Midday Briefing: Traders Await Key U.S. Inflation Data This Week
Morningstar· 3 days agoEuropean shares traded lower on Monday as investors awaited U.S. inflation data later in the week. "Much hinges on the U.S. April inflation report, with a lower reading boosting odds of a Fed ...
Earnings call: Editas Medicine outlines strategic pillars for 2024 By Investing.com
Investing.com· 7 days agoEditas Medicine (NASDAQ:EDIT) has reported significant strides in its first quarter of 2024,...